Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/280812 
Year of Publication: 
2023
Series/Report no.: 
ECIPE Policy Brief No. 05/2023
Publisher: 
European Centre for International Political Economy (ECIPE), Brussels
Abstract: 
It is high time for Europe to break its relative decline in the pharmaceutical sector. Europe used to be the preeminent region in the world for Research and Development and innovation in the sector - being the location for a majority of R&D and the development of new medicines. However, its competitiveness has been going down for several decades - and, in more recent time, the pace of the decline is now accelerating. Europe is not just outpaced by the United States. Unless there is a new direction, China will soon be ahead of Europe too.
Document Type: 
Research Report

Files in This Item:
File
Size
284.85 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.